Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys

James E. Blevins, James L. Graham, Gregory J. Morton, Karen L. Bales, Michael W. Schwartz, Denis G. Baskin, Peter J Havel

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Despite compelling evidence that oxytocin (OT) is effective in reducing body weight (BW) in diet-induced obese (DIO) rodents, studies of the effects of OT in humans and rhesus monkeys have primarily focused on noningestive behaviors. The goal of this study was to translate findings in DIO rodents to a preclinical translational model of DIO. We tested the hypothesis that increased OT signaling would reduce BW in DIO rhesus monkeys by inhibiting food intake and increasing energy expenditure (EE). Male DIO rhesus monkeys from the California National Primate Research Center were adapted to a 12-h fast and maintained on chow and a daily 15% fructose-sweetened beverage. Monkeys received 2× daily subcutaneous vehicle injections over 1 wk. We subsequently identified doses of OT (0.2 and 0.4 mg/kg) that reduced food intake and BW in the absence of nausea or diarrhea. Chronic administration of OT for 4 wk (0.2 mg/kg for 2 wk; 0.4 mg/kg for 2 wk) reduced BW relative to vehicle by 3.3 ± 0.4% (~0.6 kg; P < 0.05). Moreover, the low dose of OT suppressed 12-h chow intake by 26 ± 7% (P < 0.05). The higher dose of OT reduced 12-h chow intake by 27 ±5% (P < 0.05) and 8-h fructose-sweetened beverage intake by 18 ± 8% (P < 0.05). OT increased EE during the dark cycle by 14 ± 3% (P < 0.05) and was associated with elevations of free fatty acids and glycerol and reductions in triglycerides suggesting increased lipolysis. Together, these data suggest that OT reduces BW in DIO rhesus monkeys through decreased food intake as well as increased EE and lipolysis.

Original languageEnglish (US)
Pages (from-to)R431-R438
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume308
Issue number5
DOIs
StatePublished - 2015

Fingerprint

Oxytocin
Fructose
Macaca mulatta
Energy Metabolism
Weight Loss
Eating
Diet
Body Weight
Lipolysis
Beverages
Rodentia
Subcutaneous Injections
Nonesterified Fatty Acids
Glycerol
Nausea
Primates
Haplorhini
Diarrhea
Triglycerides
Research

Keywords

  • Energy expenditure
  • Food intake
  • Obesity
  • Oxytocin

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. / Blevins, James E.; Graham, James L.; Morton, Gregory J.; Bales, Karen L.; Schwartz, Michael W.; Baskin, Denis G.; Havel, Peter J.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 308, No. 5, 2015, p. R431-R438.

Research output: Contribution to journalArticle

Blevins, James E. ; Graham, James L. ; Morton, Gregory J. ; Bales, Karen L. ; Schwartz, Michael W. ; Baskin, Denis G. ; Havel, Peter J. / Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 2015 ; Vol. 308, No. 5. pp. R431-R438.
@article{8342e6f9836741329ca49d1550b8493e,
title = "Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys",
abstract = "Despite compelling evidence that oxytocin (OT) is effective in reducing body weight (BW) in diet-induced obese (DIO) rodents, studies of the effects of OT in humans and rhesus monkeys have primarily focused on noningestive behaviors. The goal of this study was to translate findings in DIO rodents to a preclinical translational model of DIO. We tested the hypothesis that increased OT signaling would reduce BW in DIO rhesus monkeys by inhibiting food intake and increasing energy expenditure (EE). Male DIO rhesus monkeys from the California National Primate Research Center were adapted to a 12-h fast and maintained on chow and a daily 15{\%} fructose-sweetened beverage. Monkeys received 2× daily subcutaneous vehicle injections over 1 wk. We subsequently identified doses of OT (0.2 and 0.4 mg/kg) that reduced food intake and BW in the absence of nausea or diarrhea. Chronic administration of OT for 4 wk (0.2 mg/kg for 2 wk; 0.4 mg/kg for 2 wk) reduced BW relative to vehicle by 3.3 ± 0.4{\%} (~0.6 kg; P < 0.05). Moreover, the low dose of OT suppressed 12-h chow intake by 26 ± 7{\%} (P < 0.05). The higher dose of OT reduced 12-h chow intake by 27 ±5{\%} (P < 0.05) and 8-h fructose-sweetened beverage intake by 18 ± 8{\%} (P < 0.05). OT increased EE during the dark cycle by 14 ± 3{\%} (P < 0.05) and was associated with elevations of free fatty acids and glycerol and reductions in triglycerides suggesting increased lipolysis. Together, these data suggest that OT reduces BW in DIO rhesus monkeys through decreased food intake as well as increased EE and lipolysis.",
keywords = "Energy expenditure, Food intake, Obesity, Oxytocin",
author = "Blevins, {James E.} and Graham, {James L.} and Morton, {Gregory J.} and Bales, {Karen L.} and Schwartz, {Michael W.} and Baskin, {Denis G.} and Havel, {Peter J}",
year = "2015",
doi = "10.1152/ajpregu.00441.2014",
language = "English (US)",
volume = "308",
pages = "R431--R438",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys

AU - Blevins, James E.

AU - Graham, James L.

AU - Morton, Gregory J.

AU - Bales, Karen L.

AU - Schwartz, Michael W.

AU - Baskin, Denis G.

AU - Havel, Peter J

PY - 2015

Y1 - 2015

N2 - Despite compelling evidence that oxytocin (OT) is effective in reducing body weight (BW) in diet-induced obese (DIO) rodents, studies of the effects of OT in humans and rhesus monkeys have primarily focused on noningestive behaviors. The goal of this study was to translate findings in DIO rodents to a preclinical translational model of DIO. We tested the hypothesis that increased OT signaling would reduce BW in DIO rhesus monkeys by inhibiting food intake and increasing energy expenditure (EE). Male DIO rhesus monkeys from the California National Primate Research Center were adapted to a 12-h fast and maintained on chow and a daily 15% fructose-sweetened beverage. Monkeys received 2× daily subcutaneous vehicle injections over 1 wk. We subsequently identified doses of OT (0.2 and 0.4 mg/kg) that reduced food intake and BW in the absence of nausea or diarrhea. Chronic administration of OT for 4 wk (0.2 mg/kg for 2 wk; 0.4 mg/kg for 2 wk) reduced BW relative to vehicle by 3.3 ± 0.4% (~0.6 kg; P < 0.05). Moreover, the low dose of OT suppressed 12-h chow intake by 26 ± 7% (P < 0.05). The higher dose of OT reduced 12-h chow intake by 27 ±5% (P < 0.05) and 8-h fructose-sweetened beverage intake by 18 ± 8% (P < 0.05). OT increased EE during the dark cycle by 14 ± 3% (P < 0.05) and was associated with elevations of free fatty acids and glycerol and reductions in triglycerides suggesting increased lipolysis. Together, these data suggest that OT reduces BW in DIO rhesus monkeys through decreased food intake as well as increased EE and lipolysis.

AB - Despite compelling evidence that oxytocin (OT) is effective in reducing body weight (BW) in diet-induced obese (DIO) rodents, studies of the effects of OT in humans and rhesus monkeys have primarily focused on noningestive behaviors. The goal of this study was to translate findings in DIO rodents to a preclinical translational model of DIO. We tested the hypothesis that increased OT signaling would reduce BW in DIO rhesus monkeys by inhibiting food intake and increasing energy expenditure (EE). Male DIO rhesus monkeys from the California National Primate Research Center were adapted to a 12-h fast and maintained on chow and a daily 15% fructose-sweetened beverage. Monkeys received 2× daily subcutaneous vehicle injections over 1 wk. We subsequently identified doses of OT (0.2 and 0.4 mg/kg) that reduced food intake and BW in the absence of nausea or diarrhea. Chronic administration of OT for 4 wk (0.2 mg/kg for 2 wk; 0.4 mg/kg for 2 wk) reduced BW relative to vehicle by 3.3 ± 0.4% (~0.6 kg; P < 0.05). Moreover, the low dose of OT suppressed 12-h chow intake by 26 ± 7% (P < 0.05). The higher dose of OT reduced 12-h chow intake by 27 ±5% (P < 0.05) and 8-h fructose-sweetened beverage intake by 18 ± 8% (P < 0.05). OT increased EE during the dark cycle by 14 ± 3% (P < 0.05) and was associated with elevations of free fatty acids and glycerol and reductions in triglycerides suggesting increased lipolysis. Together, these data suggest that OT reduces BW in DIO rhesus monkeys through decreased food intake as well as increased EE and lipolysis.

KW - Energy expenditure

KW - Food intake

KW - Obesity

KW - Oxytocin

UR - http://www.scopus.com/inward/record.url?scp=84923869684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923869684&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00441.2014

DO - 10.1152/ajpregu.00441.2014

M3 - Article

C2 - 25540103

AN - SCOPUS:84923869684

VL - 308

SP - R431-R438

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5

ER -